dsg2402
New Poster
Offline

I love YaBB 1G - SP1!
Posts: 5
greenwich, USA, CT, Connecticut
|
My five year old daughter Portia has just been diagnosed with moyamoya syndrome. Her ancestry is half (Han) Chinese (mom's side) and half caucasian.
Her presentation began about 1.5 years ago with frontal headaches at 3-4 am. The headache would get more intense over several hours and then she would vomit suddenly, once or twice, and seem to recover.
After visiting a pediatrician and a neurologist, and having CT scans and MRI's done, we were told that she was having "migraines." The concern had been a brain tumor, but nothing was seen in the studies.
At the peak, the frequency of attacks was twice a week. The frequency/severity of the "migraines" then decreased over a year, eventually reaching once a month. About a week ago, she had a really bad headache and displayed pronounced weakness on the right side. When a cerebral angiogram was performed, she was diagnosed with moyamoya syndrome. The attack was evidently a stroke. There is very little apparent impairment -- just a touch of weakness on the right side.
Her surgeon is Mark Souweidane at Weill Cornell, and we expect to operate on Thursday.
That's the story. Any advice, comments, and suggestions are welcome.
Is there any role for pharmacological agents in moyamoya? I noticed a promising study with a calcium channel blocker, nicardipine, for refractory childhood moyamoya. Does anybody have experience with ergoloid mesylates (e.g. Hydergine, Nicergoline) or vinpocetine -- reputed to improve cerebral circulation and provide neuroprotection? CDP-choline?
Thanks.
|